| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.76▼ | 6.69▲ | 6.71▲ | 7.29▼ | 6.24▲ |
| MA10 | 6.74▼ | 6.70▲ | 6.92▼ | 6.92▼ | 5.71▲ |
| MA20 | 6.69▲ | 6.97▼ | 7.20▼ | 5.90▲ | 4.48▲ |
| MA50 | 6.69▲ | 7.30▼ | 7.16▼ | 5.31▲ | 4.16▲ |
| MA100 | 6.92▼ | 7.11▼ | 6.31▲ | 4.24▲ | 3.50▲ |
| MA200 | 7.21▼ | 6.14▲ | 5.63▲ | 3.92▲ | 3.26▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.012▲ | -0.007▼ | -0.090▼ | 0.115▲ | 0.327▲ |
| RSI | 53.735▲ | 34.007▼ | 35.778▼ | 60.692▲ | 67.486▲ |
| STOCH | 73.462 | 32.021 | 10.338▼ | 81.146▲ | 75.845 |
| WILL %R | -34.884 | -82.278▼ | -84.358▼ | -32.530 | -22.500▲ |
| CCI | 29.810 | -24.409 | -67.235 | 37.169 | 117.901▲ |
|
Monday, December 01, 2025 01:24 PM
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that it will host a conference ...
|
|
Thursday, November 20, 2025 10:55 PM
Research and development expenses for the third quarter of 2025 increased to $9.6 million from $8.1 million for the prior year period. The increase was primarily due to a $0.9 million increase in ...
|
|
Wednesday, November 19, 2025 10:19 AM
TARA-002, a cell-based therapy by Protara Therapeutics, shows promising results in treating lymphatic malformations in pediatric patients.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/12/25 | 7.27 | 7.27 | 6.59 | 6.74 | 760,035 |
| 28/11/25 | 7.40 | 7.54 | 7.28 | 7.38 | 309,790 |
| 26/11/25 | 7.59 | 7.69 | 7.40 | 7.405 | 444,793 |
| 25/11/25 | 7.51 | 7.7899 | 7.21 | 7.56 | 731,181 |
| 24/11/25 | 7.30 | 7.82 | 7.27 | 7.37 | 763,031 |
| 21/11/25 | 6.47 | 7.59 | 6.44 | 7.26 | 1,674,309 |
| 20/11/25 | 6.71 | 7.06 | 6.41 | 6.44 | 1,032,347 |
| 19/11/25 | 6.38 | 6.71 | 6.005 | 6.71 | 1,483,052 |
| 18/11/25 | 5.53 | 6.85 | 5.39 | 6.75 | 1,648,478 |
| 17/11/25 | 5.49 | 5.75 | 5.39 | 5.57 | 478,879 |
|
|
||||
|
|
||||
|
|